Stocks · Health care · Pharmaceutical Preparations

Abbott Laboratories

ABT Clue Score62
United States Fiscal year ends December CIK 0000001800 Results filed 21 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
John A. McCoy Jr.
2 Sep 2026
Vice President and Controller
Sell
27
$109.54
$2.96K
Robert B Ford
25 Aug 2026
Chairman and CEO
Sold after exercise
180,297
$116.19
$20.95M
Robert B Ford
25 Aug 2026
Chairman and CEO
Sold after exercise
218,535
$115.57
$25.26M
Louis H. Morrone
11 Aug 2026
Executive Vice President
Sell
5,850
$109.83
$642.51K
John G Stratton
7 May 2026
Director
Buy
2,000
$86.82
$173.64K
Daniel J Starks
27 Apr 2026
Director
Buy
10,000
$92.65
$926.54K
Philip P Boudreau
23 Apr 2026
EVP and CFO
Buy indirect
2,200
$91.50
$201.30K
Elizabeth C. Cushman
2 Mar 2026
EVP, GC and Secretary
Sell
263
$115.58
$30.40K
John A. McCoy Jr.
2 Mar 2026
Vice President and Controller
Sell
585
$115.58
$67.61K
Mary K Moreland
2 Mar 2026
Executive Vice President
Sell
613
$115.58
$70.85K
Louis H. Morrone
2 Mar 2026
Executive Vice President
Sell
1,144
$115.58
$132.22K
Daniel Gesua Sive Salvadori
2 Mar 2026
EVP and Group President
Sell
885
$115.58
$102.29K
Eric Shroff
2 Mar 2026
Senior Vice President
Sell
709
$115.58
$81.95K
Daniel J Starks
4 Feb 2026
Director
Buy
5,033
$108.33
$545.24K
Daniel J Starks
4 Feb 2026
Director
Buy
4,967
$109.14
$542.09K
Robert B Ford
23 Jan 2026
Chairman and CEO
Buy indirect
18,800
$107.13
$2.01M
Eric Shroff
25 Nov 2025
Senior Vice President
Sell
1,586
$128.02
$203.04K

What was left out

Form 4 filings counted 66
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 818,930
History held since 3 Oct 2006